Cargando…
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
Current treatments for central nervous system (CNS) inflammatory demyelinating diseases (IDDs) include corticosteroids, plasma exchange, intravenous immunoglobulin, and immunosuppressant drugs. However, some patients do not respond well to traditional therapies. In recent years, novel drugs, such as...
Autores principales: | Jiao, Li, Guo, Shougang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647084/ https://www.ncbi.nlm.nih.gov/pubmed/36389702 http://dx.doi.org/10.3389/fimmu.2022.966766 |
Ejemplares similares
-
Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases
por: Ran, Zhou, et al.
Publicado: (2020) -
Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023) -
Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018) -
Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020) -
Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging
por: Huang, Chuxin, et al.
Publicado: (2022)